R Scott Huennekens
CIK 1365493 · President & Chief Executive Of · last filed 2026-06-29
R Scott Huennekens is a President & Chief Executive Of who has filed 152 SEC Form 4 insider transactions across 11 companies since 2007. The most recent filing, for QDEL, was dated Jun 29, 2026. Across all open-market trades the lifetime net is −$31.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.49M
11
152
-$30.96M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QDEL | Director | 9,352 | $16.59 | $155.1K | $0 | 4 | 2026-06-29 |
| NPCE | Director | 2,890 | $14.05 | $40.6K | $0 | 3 | 2026-06-05 |
| NVST | Director | 82,105 | $27.76 | $2.28M | $0 | 7 | 2026-05-21 |
| Hyperfine, Inc. (QSIAW) Delisted | Director | — | $0.01 | — | $0 | 3 | 2024-06-12 |
| NUVASIVE INC (NUVA) Delisted | Director | 0 | $39.75 | $0 | $0 | 7 | 2023-09-05 |
| Acutus Medical, Inc. (AFIB) Delisted | Director | 529,349 | $0.09 | $47.6K | -$34.8K | 4 | 2023-06-15 |
| HYPR | Director | 19,586 | $0.92 | $18.0K | $0 | 4 | 2022-06-13 |
| ViewRay, Inc. (VRAY) Delisted | Director | 99,670 | $0.03 | $2.5K | $0 | 7 | 2020-06-17 |
| EndoChoice Holdings, Inc. (GI) Delisted | Director | 0 | — | — | $0 | 3 | 2016-11-23 |
| Bellerophon Therapeutics, Inc. (BLPH) Delisted | Director | — | $0.01 | — | $0 | 1 | 2015-05-14 |
| Volcano Corp (VOLC) Delisted | President & Chief Executive Of | 182,570 | — | — | -$30.93M | 104 | 2015-01-05 |
Recent Filings
152 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-29 | QDEL | Grant (A) | — | $0 | EDGAR |
| 2026-06-05 | NPCE | Grant (A) | +2,890 | $0 | EDGAR |
| 2026-06-02 | QDEL | Mixed | +6,829 | $0 | EDGAR |
| 2026-05-21 | NVST | Grant (A) | +12,585 | $0 | EDGAR |
| 2025-06-12 | NVST | Grant (A) | +14,370 | $0 | EDGAR |
| 2025-06-09 | NPCE | Grant (A) | — | $0 | EDGAR |
| 2025-06-02 | QDEL | Grant (A) | — | $0 | EDGAR |
| 2025-05-27 | QDEL | Mixed | +2,523 | $0 | EDGAR |
| 2025-01-08 | NPCE | Grant (A) | — | $0 | EDGAR |
| 2024-06-12 | Hyperfine, Inc. (QSIAW) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.